Does TOFACITINIB Cause Off label use? 11,736 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 11,736 reports of Off label use have been filed in association with TOFACITINIB (XELJANZ XR). This represents 7.5% of all adverse event reports for TOFACITINIB.
11,736
Reports of Off label use with TOFACITINIB
7.5%
of all TOFACITINIB reports
1,767
Deaths
3,218
Hospitalizations
How Dangerous Is Off label use From TOFACITINIB?
Of the 11,736 reports, 1,767 (15.1%) resulted in death, 3,218 (27.4%) required hospitalization, and 2,094 (17.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 11,736 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
Rash (8,889)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TOFACITINIB Alternatives Have Lower Off label use Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN